Anticoagulation UK helps those impacted by thrombotic disorders such as atrial fibrillation, stroke, deep vein thrombosis (DVT) and pulmonary embolism (PE). Anyone taking anticoagulation medications such as Apixaban, Dabigatran, Edoxaban, Rivaroxaban and Warfarin. So why have we changed our name from Anticoagulation Europe to anticoagulation UK? Quite simply, we want to focus on our continuing commitment to provide information, education and support to the anticoagulation patient community and their health care professionals. We have retained our aims and values our new Prevention, Provision and Promotion strategy. We will continue to work with our European colleagues ensuring that we are able to contribute to the valuable research and development undertaken to promote effective anticoagulation treatments.